Home › Funds › AWM Investment Company, Inc. › DFTX
AWM Investment Company, Inc. position in DFTX
DEFINIUM THERAPEUTICS INC · Health Care
AWM Investment Company, Inc. reported holding 764,800 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$29.1M, representing 2.81% of its reported portfolio and ranking #9 among its reported holdings. AWM Investment Company, Inc. has disclosed DFTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How AWM Investment Company, Inc.'s DFTX position evolved
AWM Investment Company, Inc. first disclosed a stake in DFTX in Q4 2025 at 1,390,662 shares (US$18.6M). The position peaked in Q2 2026 at 784,800 shares, worth US$36.9M. Across 4 filings, AWM Investment Company, Inc. increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 764,800 shares valued at US$29.1M — a reduction of -20,000 shares quarter over quarter.. Notable position changes include a 27% trim in Q2 2026 (shares fell 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.39M | $18.62M | New |
| Q1 2026 | 1.08M | $20.35M | Reduce |
| Q2 2026 | 784.80K | $36.92M | Reduce |
| Q3 2026 | 764.80K | $29.11M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DFTX and 13F data
DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 154 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DFTX
- Avoro Capital Advisors LLC 7.19M sh · $338.17M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 6.85M sh · $322.00M · Q2 2026
- Octagon Capital Advisors LP 2.95M sh · $138.77M · Q2 2026
- Deep Track Capital, LP 2.75M sh · $129.36M · Q2 2026
- Commodore Capital LP 2.00M sh · $94.08M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.50M sh · $70.56M · Q2 2026
- Boxer Capital Management, LLC 998.50K sh · $46.97M · Q2 2026
- ArrowMark Colorado Holdings LLC 564.07K sh · $26.53M · Q2 2026
- Catalio Capital Management, LP 562.67K sh · $26.47M · Q2 2026
- Integral Health Asset Management, LLC 550.00K sh · $25.87M · Q2 2026
- GREAT POINT PARTNERS LLC 425.00K sh · $19.99M · Q2 2026
- Ally Bridge Group (NY) LLC 400.00K sh · $18.82M · Q2 2026
More on AWM Investment Company, Inc.
FAQ
How long has AWM Investment Company, Inc. held DFTX?
AWM Investment Company, Inc. has disclosed DFTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is AWM Investment Company, Inc.'s current position in DFTX?
As of Q3 2026, AWM Investment Company, Inc. holds 764.80K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $29.11M, representing 2.81% of its reported portfolio and ranking #9.
Has AWM Investment Company, Inc. been buying or selling DFTX?
In the latest 13F filing (Q3 2026), AWM Investment Company, Inc. reduced its position in DFTX. The position peaked in Q2 2026 at 784.80K shares.
Which other funds hold DFTX?
Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 154 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.